Table 2.
MK-0752 mg/m2* | No. of Patients Enrolled | No. of Patients Evaluable | No. of Patients With DLT | DLT |
---|---|---|---|---|
200 | 3 | 3 | 0 | |
260 | 6 | 6 | 2 | Grade 3 AST (n = 2); grade 3 ALT (n = 2)† |
260 (expanded PK cohort) | 14 | 12 | 1 | Grade 3 ALT (n = 1) |
Abbreviations: DLT, dose-limiting toxicity; PK, pharmacokinetics.
Dosage is expressed in mg/m2/dose administered 3 days on, 4 days off.
Both patients had both AST and ALT DLTs.